With histopathological interpretation of the H&E slides, we determined that the tumor tissue architecture of Sirt2−/− HCC tumors was indeed different from that of Sirt2+/+ HCC tumors (Figure 4). The gene discussed is SIRT2; the disease is hepatocellular carcinoma.